Cite
HARVARD Citation
Pasalic, D. et al. (2020). Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. European journal of cancer. pp. 176-185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pasalic, D. et al. (2020). Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. European journal of cancer. pp. 176-185. [Online].